Skip to content

Patrick C Dolder

Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.

4 papers in the library · 352 citations · publishing 2016-2024

Papers

Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Biological psychiatry February 1, 2023 Friederike Holze, Peter Gasser, Felix Müller et al. 294 citations

LSD-assisted therapy produced long-lasting reductions in anxiety and comorbid depression symptoms up to 16 weeks in patients with anxiety related to a life-threatening illness. In a double-blind, placebo-controlled crossover trial with 42 patients, LSD treatment led to significant decreases in anxiety scores compared to placebo, with a large effect size. Similar improvements were seen in depression ratings. Positive acute subjective drug effects and mystical-type experiences correlated with long-term anxiety reductions. Mild, transient side effects occurred in 19% of patients, and one serious adverse event (acute transient anxiety) was reported.

Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.

BMC pharmacology & toxicology May 26, 2016 Evangelia Liakoni, Patrick C Dolder, Katharina M Rentsch et al. 24 citations

Of 50,624 emergency department visits at a Swiss university hospital over one year, 210 were due to acute recreational drug toxicity. Patients averaged 33 years old, 73% were male. Cocaine (33%), cannabis (32%), and heroin (14%) were the most reported substances; analytical testing confirmed cannabis (33%), cocaine (27%), and opioids excluding methadone (19%) most often. Only two cases involved novel psychoactive substances (NPS): one severe intoxication with PMMA and one minor with 2C-P. Common symptoms included tachycardia (28%), anxiety (23%), nausea or vomiting (18%), and agitation (17%). Severe outcomes included two deaths, two heart attacks, 13 seizures, and six psychosis cases. Most patients (76%) were discharged; 10% required intensive care. Classic drugs like cocaine and cannabis caused most problems, while NPS were rarely seen despite their increased detection elsewhere.

Mistaking 2C-P for 2C-B: What a Difference a Letter Makes.

Journal of analytical toxicology January 1, 2017 Adrian Stoller, Patrick C Dolder, Michael Bodmer et al. 19 citations

A 19-year-old male was admitted to the emergency department with severe hallucinations, dilated pupils, rapid heart rate, agitation, and confusion after using a substance sold as 2C-B. Laboratory analysis using liquid chromatography-mass spectrometry detected the more potent synthetic phenethylamine derivative 2C-P instead. Based on two blood samples, the estimated elimination half-life was 19 hours. The case illustrates how small structural variations in the 4 position of the phenyl ring, such as a propyl group in 2C-P versus bromine in 2C-B, can lead to significant differences in drug potency and duration of action, contributing to adverse effects.

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Translational psychiatry September 4, 2024 Patrick Vizeli, Erich Studerus, Friederike Holze et al. 15 citations

LSD dose is the strongest predictor of the drug's subjective and autonomic effects, but non-pharmacological factors also play a significant role. Pre-drug mood states—such as well-being, emotional excitability, and anxiety—predict subjective effects, heart rate, and body temperature. The personality trait openness to experiences correlates with stronger mystical-type effects and oceanic boundlessness. Prior hallucinogen use is linked to less anxious ego dissolution and a less intense overall altered state. Acute anxiety relates negatively to the functionality of the Cytochrome 2D6 enzyme. Sex and body weight do not significantly influence the drug experience.